摘要
目的:观察新药云克治疗类风湿性关节炎的临床疗效。方法:按1987年美国风湿协会诊断类风湿性关节炎(RA)的标准,对76例RA患者进行1疗程～7疗程的治疗。结果:对轻度和中度的RA患者应用云克效果明显,有效率达88.2％。结论:新药云克可能是治疗RA的理想药物。
OBJECTIVE:To observe the therapeutic effect of YunKe, a new drug, on rheumatic arthritis(RA). METHODS: According to the RA standard formulated by American Rheumatism Association in 1987,1 - 7 therapeutic courses were carried out in 76 cases of RA with administration of YunKe. RESULTS: Marked effects of YunKe were observed in patients with mild and moderate RA with an effective rate of 88. 2% . CONCLUSION:New drug, YunKe, may be an ideal drug for RA.
出处
《中国医院用药评价与分析》
2001年第1期41-42,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
